Abstract
Stem cells comprise the central core of every tissue within our organism. They are unspecialized cells, able to divide for long periods, and give rise to all differentiated cells in the body.
Current therapies of advance tissue failure require ultimately their replacement by organ transplantation, which involves complex procedures and chronic severe adverse effects. Regenerative medicine arose from the demand to provide alternative effective treatment for this population, replacing human cells through tissue regeneration.
This novel field displays several therapeutic strategies, from directed cell therapy to tissue bioengineering, demonstrating in numerous research trials neoangiogenic and immunomodulatory properties. Distinctive types of stem cell have been recognized. Embryonic stem cells have been proven to differentiate into cells from all three embryonic germ layers, while tissue-specific stem cells maintain organ homeostasis and differentiate into the specialized cells types from where they reside. Induced pluripotent stem cells are adult somatic cells genetically reprogrammed to an embryonic stem cell-like state, resulting in pluripotency capability. Meanwhile, in the blood from the placenta and umbilical cord, umbilical stem cells can be isolated.
Stem cell-based therapies have been proven to have adequate safety profiles and therapeutic effects in a number of pathological conditions in aesthetic medicine, from unsuccessful wound healing to adipose graft in soft tissue filling, employing biomaterials in cartilage defects and bone reconstruction, and promoting antiaging mechanisms in damaged skin. However, several issues need to be properly addressed before their full potential can be realized.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bongso A, Richards M. History and perspective of stem cell research. Best Pract Res Clin Obstet Gynaecol. 2004;18:827–42.
Rosenthal N. Prometheus’s vulture and the stem-cell promise. N Engl J Med. 2003;349:267–74.
Polykandriotis E, Popescu LM, Horch RE. Regenerative medicine: then and now—an update of recent history into future possibilities. J Cell Mol Med. 2010;14(10):2350–8.
European Molecular Biology Organization (EMBO). Stem Cell Research. 2006: 1–77.
Orlando G, Wood KJ, Stratta RJ, et al. Regenerative medicine and organ transplantation: past, present, and future. Transplantation. 2011;91:1310–7.
Thompson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.
Mason C, Dunnill P. A brief definition of regenerative medicine. Regen Med. 2008:1–5.
Mao AS, Mooney DJ. Regenerative medicine: current therapies and future directions. PNAS. 2015;112:14452–9.
Alison MR, Poulsom R, Forbes S, et al. An introduction to stem cells. J Pathol. 2002;197:419–23.
Smith AG. Embryo-derived stem cells of mice and men. Annu Rev Cell Dev Biol. 2001;17:435–62.
Al-Himdani S, Jessop ZM, Al-Sabah A, et al. Tissue-engineered solutions in plastic and reconstructive surgery: principles and practice. Front Surg. 2017;4:4.
Bjornson CR, Rietze RL, Reynolds BA, et al. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo. Science. 1999;283:534–7.
Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci. 1981;78:7634–8.
Bajada S., Mazakova I., Ashton B.A., et al. Stem cells in regenerative medicine. Topics in Tissue Engineering. 2008, Vol. 4. Eds. N Ashammakhi, R Reis, & F Chiellini.
Briggs R, King TJ. Transplantation of living nuclei from blastula cells into enucleated frogs eggs. Proc Natl Acad Sci. 1952;38:455–63.
Morrison S, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell. 1997:287–98.
Abdelkrim H, Domínguez-Bendala J. The immune boundaries for stem cell based therapies: problems and prospective solutions. J Cell Mol Med. 2009;13:1464–75.
Watt FM, Hogan BL. Out of Eden: stem cells and their niches. Science. 2000;287:1427–30.
Stem cell facts. International Society for Stem Cell Research. 2011.
Priest RE, Marimuthu KM, Priest JH. Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Investig. 1978;39:106–9.
De Coppi P, Bartsch G, Sidddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Natl Biotechnol. 2007;25:100–6.
Houlihan JM, Biro PA, Harper HM, et al. The human amnion is a site of MHC class Ib expression: evidence for the expression of HLA-E and HLA-G. J Immunol. 1995;154:5665–74.
Taylor A, Verhagen J, Blaser K, et al. Mechanisms of immune suppression by interleukin-10 and transforming growth factor beta: the role of T regulatory cells. Immunology. 2006;117:433–42.
Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006;22:339–73.
Sassi OK, Marinowic D, Brum DE, et al. Stem cells in dermatology. An Bras Dermatol. 2014;89:286–91.
Kim YJ, Jeong JH. Clinical application of adipose stem cells in plastic surgery. J Korean Med Sci. 2014;29:462–7.
Ojeh N, Pastar I, Tomic-Canic M, et al. Stem cells in skin regeneration, wound healing, and their clinical applications. Int J Mol Sci. 2015;16:25476–501.
Rodriguez-Menocal L, Shareef S, Salgado M. Role of whole bone marrow, whole bone marrow cultured cells, and mesenchymal stem cells in chronic wound healing. Stem Cell Res Ther. 2015;6:1–11.
Sorrell JM, Caplan AI. Topical delivery of mesenchymal stem cells and their function in wounds. Stem Cell Res Ther. 2010;1:30.
Toyserkani NM, Christensen ML, Sheikh SP, Sørensen JA. Adipose-derived stem cells new treatment for wound healing? Ann Plast Surg. 2015;75:117–23.
Kim JH, Jung M, Kim HS, et al. Adipose-derived stem cells as a new therapeutic modality for ageing skin. Exp Dermatol. 2011;20:383–7.
Li J, Ezzelarab MB, Cooper DK. Do mesenchymal stem cells function across species barriers? Relevance for xenotransplantation. Xenotransplantation. 2012;19:273–85.
Yun IS, Jeon YR, Lee WJ, et al. Effect of human adipose derived stem cells on scar formation and remodeling in a pig model: a pilot study. Dermatol Surg. 2012;38:1678–88.
Oliveira SM, Reis RL, Mano JF. Towards the design of 3D multiscale instructive tissue engineering constructs: current approaches and trends. Biotechnol Adv. 2015;33:842–55.
Zhu X, Cui W, Li X, et al. Electrospun fibrous mats with high porosity as potential scaffolds for skin tissue engineering. Biomacromolecules. 2008;9:1795–801.
Rustad KC, Wong VW, Sorkin M, et al. Enhancement of mesenchymal stem cell angiogenic capacity and stemness by a biomimetic hydrogel scaffold. Biomaterials. 2012;33:80–90.
Lee V, Singh G, Trasatti JP, et al. Design and fabrication of human skin by three-dimensional bioprinting. Tissue Eng. 2014;20:473–84.
Liu S, Zhang H, Zhang X, et al. Tissue Synergistic angiogenesis promoting effects of extracellular matrix scaffolds and adipose-derived stem cells during wound repair. Tissue Eng Part A. 2011;17:725–39.
Lin YC, Grahovac T, Oh SJ, et al. Evaluation of a multi-layer adipose-derived stem cell sheet in a full-thickness wound healing model. Acta Biomater. 2013;9:5243–50.
Compton CC, Nadire KB, Regauer S, et al. Cultured human sole-derived keratinocyte grafts re-express site-specific differentiation after transplantation. Differentiation. 1998;64:45–53.
Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441–50.
Shabbir A, Cox A, Rodriguez-Menocal L, et al. Mesenchymal stem cell exosomes induce proliferation and migration of normal and chronic wound fibroblasts, and enhance angiogenesis in vitro. Stem Cells Dev. 2015;24:1635–47.
Baglio SR, Rooijers K, Koppers-Lalic D, et al. Human bone marrow- and adipose-mesenchymal stem cells secrete exosomes enriched in distinctive mirna and tRNA species. Stem Cell Res Ther. 2015;6:1–20.
Witkowska-Zimny M, Walenko K. Stem cells from adipose tissue. Cell Mol Biol Lett. 2011;16:236–57.
Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548–56.
Gaur M, Dobke M, Lunyak VV. Mesenchymal stem cells from adipose tissue in clinical applications for dermatological indications and skin aging. Int J Mol Sci. 2017;18:1–29.
Fraser JK, Hicok KC, Shanahan R, et al. The celution system: automated processing of adipose-derived regenerative cells in a functionally closed system. Adv Wound Care. 2014;3:38–45.
Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002;13:4279–95.
Deslex S, Negrel R, Vannier C, et al. Differentiation of human adipocyte precursors in a chemically defined serum-free medium. Int J Obes. 1987;11:19–27.
Toyserkani NM, Christensen ML, Sheikh SP, et al. Adipose-derived stem cells. New treatment for wound healing? Ann Plast Surg. 2015;75:117–23.
Rehman J, Traktuev D, Li J, et al. Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation. 2004;109:1292–8.
Lee EY, Xia Y, Kim WS, et al. Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF. Wound Repair Regen. 2009;17:540–7.
Gir P, Brown SA, Oni G, et al. Fat grafting: evidence-based review on autologous fat harvesting, processing, reinjection, and storage. Plast Reconstr Surg. 2012;130:249–58.
Jeong JH. Adipose stem cells and skin repair. Curr Stem Cell Res Ther. 2010;5:137–40.
Matsumoto D, Sato K, Gonda K, et al. Cell-assisted lipotransfer: supportive use of human adipose-derived cells for soft tissue augmentation with lipoinjection. Tissue Eng. 2006;12:3375–82.
Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adiposederived stem cells. Dermatol Surg. 2008;34:1178–85.
Lee SK, Kim DW, Dhong ES, et al. Facial soft tissue augmentation using autologous fat mixed with stromal vascular fraction. Arch Plast Surg. 2012;39:534–9.
Kim M, Kim I, Lee SK, et al. Clinical trial of autologous differentiated adipocytes from stem cells derived from human adipose tissue. Dermatol Surg. 2011;37:750–9.
Garcia-Olmo D, Garcia-Arranz M, Herreros D, et al. A phase I clinical trial of the treatment of Crohn’s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum. 2005;48:1416–23.
Rodriguez AM, Pisani D, Dechesne CA, et al. Transplantation of a multipotent cell population from human adipose tissue induces dystrophin expression in the immunocompetent mdx mouse. J Exp Med. 2005;201:1397–405.
Cousin B, Andre M, Arnaud E, et al. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun. 2003;301:1016–22.
Salibian AA, Widgerow AD, Abrouk M, et al. Stem cells in plastic surgery: a review of current clinical and translational applications. Arch Plast Surg. 2013;40:666–75.
Lee EH, Hui JH. The potential of stem cells in orthopaedic surgery. J Bone Jt Surg. 2006;88:841–53.
Dhinsa BS, Adesida AB. Current clinical therapies for cartilage repair, their limitation and the role of stem cells. Curr Stem Cell Res Ther. 2012;7:143–8.
Vidal MA, Robinson SO, Lopez MJ, et al. Comparison of chondrogenic potential in equine mesenchymal stromal cells derived from adipose tissue and bone marrow. Vet Surg. 2008;37:713–24.
Koga H, Shimaya M, Muneta T, et al. Local adherent technique for transplanting mesenchymal stem cells as a potential treatment of cartilage defect. Arthritis ResTher. 2008;10:R84.
Centeno CJ, Schultz JR, Cheever M, et al. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011;6:368–78.
Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med. 2007;1:74–9.
Haleem AM, Singergy A, Sabry D, et al. The clinical use of human cultureexpanded autologous bone marrowmesenchymal stemcells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results. Cartilage. 2010;1:253–61.
Peeters CM, Leijs MJ, Reijman M, et al. Safety of intraarticular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthr Cartil. 2013;21:1465–73.
Shafiee A, Soleimani M, Chamheidari GA, et al. Electrospun nanofiber-based regeneration of cartilage enhanced by mesenchymal stem cells. J Biomed Mater Res. 2011;99:467–78.
Ramakrishna V, Janardhan PB, Sudarsanareddy L. Stem cells and regenerative medicine—a review. Ann Rev Res Biol. 2011;1:79–110.
Deschaseaux F, Pontikoglou C, Luc S. Bone regeneration: the stem/progenitor cells point of view. J Cell Mol Med. 2010;14:103–15.
Lendeckel S, Jodicke A, Christophis P, et al. Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. J Craniomaxillofac Surg. 2004;32:370–3.
Mesimaki K, Lindroos B, Tornwall J, et al. Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. Int J Oral Maxillofac Surg. 2009;38:201–9.
Warnke PH, Springer IN, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet. 2004;364:766–70.
Sandor GK, Tuovinen VJ, Wolff J, et al. Adipose stem cell tissue-engineered construct used to treat large anterior mandibular defect: a case report and review of the clinical application of good manufacturing practice-level adipose stem cells for bone regeneration. J Oral Maxillofac Surg. 2013;71:938–50.
Fisher GJ, Datta SC, Talwar HS, et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature. 1996;379:335–9.
Stevenson S, Sharpe DT, Thornton MJ. Effects of oestrogen agonists on human dermal fibroblasts in an in vitro wounding assay. Exp Dermatol. 2009;18:988–90.
Saintigny G, Bernard FX, Juchaux F, et al. Reduced expression of the adhesion protein tensin1 in cultured human dermal fibroblasts affects collagen gel contraction. Exp Dermatol. 2008;17:788–9.
Bednarska K, Kieszek R, Domagała P, et al. The use of platelet-rich-plasma in aesthetic and regenerative medicine. MEDtube Sci. 2015;3:8–15.
Godic A, Poljšak B, Adamic M, et al. The role of antioxidants in skin cancer prevention and treatment oxidative medicine and cellular longevity. Oxidative Med Cell Longev. 2014;860479:1–6.
Banihashemi M, Nakhaeizadeh S. An introduction to application of platelet rich plasma (PRP) in skin rejuvenation. Rev Clin Med. 2014;1:38–43.
Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–96.
Amable PR, Carias RB, Teixeira MV, et al. Plateletrich plasma preparation for regenerative medicine: optimization and quantification of cytokines andgrowth factors. Stem Cell Res Ther. 2013;4:67.
Graziani F, Ivanovski S, Cei S, et al. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res. 2006;17:212–9.
Kakudo N, Minakata T, Mitsui T, et al. Proliferation-promoting effect of platelet-rich plasma on human adipose-derived stem cells and human dermal fibroblasts. Plast Reconstr Surg. 2008;122:1352–60.
Kim DH. Can platelet-rich plasma be used for skin rejuvenation? Evaluation of effects of platelet-rich plasma on human dermal fibroblast. Ann Dermatol. 2011;23:424–31.
Karussis D, Karageorgiou C, Vaknin-Dembinsky A, et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol. 2010;67:1187–94.
Le Blanc K, Frassoni F, Ball L, et al. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet. 2008;371:1579–86.
Shin TH, Kim HS, Choi SW, et al. Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action. Int J Mol Sci. 2017;18:1–25.
Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood. 2005;105:2821–7.
Zhou H, Guo M, Bian C, et al. Efficacy of bone marrow-derived mesenchymal stem cells in the treatment of sclerodermatous chronic graft-versus-host disease: clinical report. Biol Blood Marrow Transplant. 2010;16:403–12.
Liang J, Zhang H, Hua B, et al. Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis. 2010;69:1423–9.
Campanati A, Orciani M, Consales V, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis. Arch Dermatol Res. 2014;306:915–20.
Kim HS, Lee JH, Roh KH, et al. Clinical trial of human umbilical cord blood-derived stem cells for the treatment of moderate-to-severe atopic dermatitis: phase I/IIa studies. Stem Cells. 2017;35:248–55.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sutelman, P. (2019). Stem Cell Research in Aesthetic Medicine. In: Pinto, H., Fontdevila, J. (eds) Regenerative Medicine Procedures for Aesthetic Physicians. Springer, Cham. https://doi.org/10.1007/978-3-030-15458-5_20
Download citation
DOI: https://doi.org/10.1007/978-3-030-15458-5_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-15457-8
Online ISBN: 978-3-030-15458-5
eBook Packages: MedicineMedicine (R0)